Clinical Trial Update: A Double-blind Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo [Phase 1, Phase 2]

View source ↗

Summary

A double-blind randomized placebo-controlled study evaluating safety and immunogenicity of GamEvac-Lyo in healthy volunteers (Phase 1/2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• GamEvac-Lyo (GamEvac-Lyo)

Snippet

Sponsor: Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | Conditions: Healthy Volunteers | Phase 1, Phase 2 | Status: COMPLETED